glp 1 agonist heart disease GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 receptor agonists and cardiovascular

findMySequence: a neural-network-based approach for identification of unknown proteins in X-ray crystallography and cryo-EM

10.1089/bio.2018.0037 36

Mitochondria are central to metabolic activities in cells, so any disturbance in their functions can lead to profoundly altered generation of adenine triphosphate (ATP)

We conducted descriptive and comparative analyses to explore mortality, latency to onset, the relationship between prior drug-allergy history and SJS/TEN phenotype and mortality, and the characteristics and classification of implicated drugs, thereby providing preliminary insights into the clinical features and potential immunologic mechanisms underlying concurrent DILI and SJS/TEN

KPV reduces the inflammatory signaling from chronic hyperglycemia that drives ongoing nerve injury